Barclays raised the firm’s price target on Cencora (COR) to $425 from $400 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COR:
- Cencora Issues $3 Billion in Senior Unsecured Notes
- Cencora Updates Segment Reporting Following Strategic Business Review
- Cencora price target raised to $419 from $417 at JPMorgan
- Cencora price target raised to $429 from $405 at Wells Fargo
- Cencora: OneOncology Acquisition and Conservative Guidance Underscore Upside to $400 Target